Comparative analysis uncovers metabolic pathways in COVID-19 and liver diseases, suggesting new biomarkers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Juyal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: